HF-1-K-16

全反式维甲酸脂质体（杭州高田生物）

Report date: 2025/09/03 17:52:47

Base Information

Drug NameHF-1-K-16
Drug Alias NameTretinoin liposomal(HighField Biopharmaceuticals Corporation)HF1K16HF-1K16(HighField Biopharmaceuticals Corporation)
ClassificationSmall molecules > Amino acid supplement, Lipids and Vitamins
Mechanisms of ActionProtein synthesis inhibitorsRetinoic acid receptors inhibitors
TargetsRetinoic acid receptors
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungPancreatic Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesHighField Biopharmaceuticals Corp
China Registration ClassN/A

Develop Information

Active CompaniesHighField Biopharmaceuticals CorpHighField Biopharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungPancreatic Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A